Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings Amid Booming Demand For Weight Loss And Diabetes DrugsForbes • 08/07/24
Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024GlobeNewsWire • 08/07/24
Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss DrugThe Motley Fool • 08/03/24
Novo Nordisk GLP-1 drug shows encouraging signs in early stage Alzheimer's trialProactive Investors • 07/30/24
For Alzheimer's patients, this Novo Nordisk GLP-1 drug slows cognitive decline, study findsMarket Watch • 07/30/24
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study saysCNBC • 07/30/24
What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?The Motley Fool • 07/29/24